drug
as of 2026-07-01NAVIGATE
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
SchizophreniaAffective Disorders, PsychoticPsychological Well-BeingPsychosisSchizophreniform DisordersSchizophrenia, ChildhoodSchizophrenia Spectrum and Other Psychotic DisordersFirst Episode PsychosisAffective Disorders, PsychoticSchizophreniaPsychotic Disorder Due to Unspecified SubstanceSchizophrenia, ChildhoodPsychotic DisordersBipolar I DisorderSchizoaffective DisorderSchizophrenia Spectrum and Other Psychotic Disorders
Trials
1
Early Psychosis Intervention - Spreading Evidence-based Treatment
NCT03919760—Completed
KOLs & investigators
5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
indication
indication
indication
indication
indication
KOL
George Foussias, MD PhD FRCPC
personKOL score 8
Paul Kurdyak, MD, PhD
personKOL score —
Sanjeev Sockalingam, MD
personKOL score —
Aristotle N Voineskos, MD, PhD
personKOL score —